Skip to main content

    Main navigation

    • Investors
    • About
    • News
    • Contact us
    • Egoo.health
    • en
    • sv
Home

Main navigation

  • Investors
  • About
  • News
  • Contact us
  • Egoo.health
  • en
  • sv
2019-10-14 10:51

Qlife participates at Intrum Stockholm Open on 18 October 2019!

Six interesting companies in total will present their businesses.

Watch the video of the presentation

2022-05-12 09:00
Qlife’s new filtration unit significantly broadens the market for the Egoo platform
2022-05-05 13:10
Bulletin from the annual general meeting in Qlife Holding AB 5 May 2022
2022-05-05 09:30
QLIFE HOLDING AB, QUARTERLY REPORT Q1 2022
2022-04-06 13:00
QLIFE PUBLISHES ANNUAL REPORT 2021
2022-04-04 08:00
Notice of annual general meeting in Qlife Holding AB
2022-03-28 10:42
Qlife study follow up - deviations in test execution explain incorrect results
2022-02-17 10:12
Qlife to follow up Danish clinical evaluation on rapid tests for covid-19
2022-02-17 09:30
QLIFE HOLDING AB, YEAR END REPORT 2021, Q4
2021-12-20 16:00
Qlife receives 3,45 MUSD funding from FIND to develop a respiratory assay in global fight against COVID-19 and influenza

Qlife

Qlife Holding AB
Redaregatan 48
SE-252 36 Helsingborg, Sweden
info@egoo.health

Links

  • About
  • Investors
  • Egoo.health

Qlife Holding AB is a med-tech group that strives to revolutionize the market for clinical biomarker and virus tests. By enabling tests at home as a complement to tests in healthcare, access to important health information that can contribute to better treatment and potential prevention of diseases is facilitated. On March 2, 2020, Qlife Holding completed a listing on the Nasdaq First North Growth Market, Stockholm. The company currently has about 40 employees.